USE OF FENOFIBRIC ACID IN THE TREATMENT OF HEPATIC DISEASES
- 专利权人:
- GENCOD
- 发明人:
- Claude LARUELLE,Ludovic BONNAFOUS
- 申请号：
- US16094183
- 公开号：
- US20190247343A1
- 申请日:
- 2017.04.13
- 申请国别(地区):
- US
- 年份:
- 2019
- 代理人:
- 摘要：
- A composition comprising as a sole active ingredient fenofibric acid or one of the pharmaceutically acceptable salts thereof for use in the treatment of liver diseases. The field relates to the treatment and prevention of liver diseases, such as non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), liver fibrosis or cirrhosis.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- PHARMACEUTICAL COMPOSITION COMPRISING RESVERATROL DERIVATIVES AS ACTIVE INGREDIENT, FOR PREVENTING OR TREATING LIVER CIRRHOSIS OR FIBROSIS
- 6''-O-6''-O-Galloylsalidroside A pharmaceutical composition for preventing or treating liver disease comprising 6''-O-Galloylsalidroside
- PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING HEPATITIS HEPATIC FIBROSIS AND HEPATIC CIRRHOSIS COMPRISING FUSION PROTEINS
- COMPOSITION FOR PREVENTION AND TREATMENT OF LIVER FIBROSIS OR LIVER CIRRHOSIS COMPRISING OF MESENCHYMAL STEM CELLS DERIVED FROM HUMAN EMBRYONIC STEM CELLS AS AN ACTIVE INGREDIENT
- COMPOSITION FOR PREVENTING AND TREATING LIVER FIBROSIS OR LIVER CIRRHOSIS, CONTAINING, AS ACTIVE INGREDIENT, MESENCHYMAL STEM CELLS DERIVED FROM HUMAN EMBRYONIC STEM CELLS
